Euprotec’s aim is to deliver the highest quality and most comprehensive range of services to accelerate the anti-infective drug discovery and development activities of its clients.
With unparalleled expertise in microbiology and infectious disease biology, Euprotec is able to support each stage of an anti-infective drug discovery and development program from proof-of-concept through to late stage preclinical investigation.
Euprotec has worked across a wide range of biological targets and with multiple classes of antimicrobial agent including small molecules, natural products, peptides and biologics.
The Company has collected, and continues to develop, an extensive library of clinical isolates known as StrainBank. This collection is a unique resource and represents a valuable tool to organisations involved in antibacterial drug discovery and development. In order to meet the future changing needs of its clients, Euprotec continues to invest in the development of new assays and models to help predict therapeutic outcome.
The company’s Core Services include:
Contact
For further enquiries, please call Dr Peter Warn or Dr Sandra Howsley on 0161 603 7624
Visit: www.euprotec.com
Email: [email protected]
